• Corpus ID: 25781275

[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.

@article{Bonhaus19933HBIMU1A5,
  title={[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.},
  author={Douglas W Bonhaus and Dana N. Loury and Lyn B. Jakeman and Z. P. To and Andre Desouza and R. M. Eglen and Erik H. F. Wong},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={1993},
  volume={267 2},
  pages={
          961-70
        }
}
  • D. BonhausD. Loury E. Wong
  • Published 1 November 1993
  • Biology, Chemistry
  • The Journal of pharmacology and experimental therapeutics
The binding of [3H]endo-N-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl)- 2,3-dihydro-3-ethyl-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride ([3H]BIMU-1) a benzimidazolone with high affinity for 5-hydroxytryptamine (5-HT)3 and 4 5-HT3 and 5-HT4 receptors, was characterized in NG-108 cells and guinea pig hippocampus. Specific, heat-sensitive, binding of [3H]BIMU-1 was detected in both NG-108 cells and guinea pig hippocampus. In NG-108 cell membranes, a portion of the specific binding was displaced… 

BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse

The ability of 5-HT4 receptor agonists to reverse spontaneous working memory deficits is demonstrated and the therapeutic potential of such ligands in the treatment of cognitive alterations that associate short-term working memory disorders and cholinergic hypofunction is confirmed.
...